| Applications and limitations of dendrimers in biomedicine AA Chis, C Dobrea, C Morgovan, AM Arseniu, LL Rus, A Butuca, ... Molecules 25 (17), 3982, 2020 | 283 | 2020 |
| Spectrophotometric method for the determination of trimetazidine dihydrochloride from pharmaceutical forms AA Chiş, FG Gligor, G Cormoş, E Curea, M Bojiţǎ Farmacia 58 (5), 629-636, 2010 | 13 | 2010 |
| Dendrimers as non-viral vectors in gene-directed enzyme prodrug therapy AA Chis, CM Dobrea, LL Rus, A Frum, C Morgovan, A Butuca, M Totan, ... Molecules 26 (19), 5976, 2021 | 11 | 2021 |
| Compatibility and stability studies of antihypertensive/excipients by thermal methods, used in the preformulation phase A Moisei, F Gligor, M Bojiţă, A Chiş, M Totan, LA Vonica-Gligor, A Ciurba Farmacia 62 (6), 1239-1248, 2014 | 11 | 2014 |
| Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing A Frum, CM Dobrea, LL Rus, LI Virchea, C Morgovan, AA Chis, ... Nutrients 14 (15), 3065, 2022 | 10 | 2022 |
| A new, rapid and efficient HPLC method to assay resveratrol in food supplements VI Craciun, FG Gligor, AM Juncan, AA Chis, LL Rus Rev. Chim 70 (9), 3202-3205, 2019 | 10 | 2019 |
| The simultaneous determination of candesartan, amlodipine and hydrochlorothiazide by high-performance liquid chromatography, from a mixture and pharmaceutical formulations A Moisei, M Totan, FG Gligor, I Crăciun, N Todoran, AA Chiş, DE Popa Farmacia 4 (64), 612-618, 2016 | 9 | 2016 |
| Biopolymeric prodrug systems as potential antineoplastic therapy AA Chis, AM Arseniu, C Morgovan, CM Dobrea, A Frum, AM Juncan, ... Pharmaceutics 14 (9), 1773, 2022 | 7 | 2022 |
| A Descriptive Analysis of Direct Oral Anticoagulant Drugs dosing errors based on spontaneous reports from the EudraVigilance database C Morgovan, CM Dobrea, AA Chis, AM Juncan, AM Arseniu, LL Rus, ... Pharmaceuticals 16 (3), 455, 2023 | 5 | 2023 |
| Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing. Nutrients. 2022; 14: 3065 A Frum, CM Dobrea, LL Rus, L Virchea, C Morgovan, AA Chis, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 5 | 2022 |
| Some Brassicaceae Extracts as Potential Antioxidants and Green Corrosion Inhibitors IMC Ienașcu, A Căta, AA Chis, MN Ştefănuț, P Sfîrloagă, G Rusu, ... Materials 16 (8), 2967, 2023 | 4 | 2023 |
| Determination of Zn2+ in Solid Pharmaceutical Dosage Forms by Means of Spectrophotometry in Micellar Media: Method Validation LL Rus, AM Juncan, VI Crăciun, A Frum, SC Hegheș, A Butuca, ... Applied Sciences 12 (9), 4476, 2022 | 3 | 2022 |
| An Assessment of Semaglutide Safety Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance Database A Butuca, CM Dobrea, AM Arseniu, A Frum, AA Chis, LL Rus, S Ghibu, ... Biomedicines 12 (5), 1124, 2024 | | 2024 |
| Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance C Morgovan, CM Dobrea, A Butuca, AM Arseniu, A Frum, LL Rus, AA Chis, ... Biomedicines 12 (5), 953, 2024 | | 2024 |
| Thrombosis and death: serious coincidental events after COVID-19 vaccination A Frum, DG Moisa, AM Juncan, LL Rus, CM Dobrea, AM Arseniu, AA Chis, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 395 (SUPPL 1), S24-S24, 2022 | | 2022 |
| The Impact of SGLT-2 inhibitors on laboratory parameters C Morgovan, DG Moisa, CM Dobrea, AM Arseniu, A Frum, AM Juncan, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 395 (SUPPL 1), S8-S8, 2022 | | 2022 |
| Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy. Pharmaceutics 2022, 14, 1773 AA Chis, AM Arseniu, C Morgovan, CM Dobrea, A Frum, AM Juncan, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Vonica-T, incu, AL; Gligor, FG; Mures, an, ML; Dobrea, CM Microbial Resistance to Antibiotics and Effective Antibiotherapy. Biomedicines 2022, 10, 1121 AA Chis, LL Rus, C Morgovan, AM Arseniu, A Frum s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| COVID-19 vaccination program in Romania: an overview on implementation and monitoring of adverse reactions C Morgovan, AM Juncan, LL Rus, AA Chis, A Arseniu, CM Dobrea, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 394 (SUPPL 1), S35-S35, 2021 | | 2021 |
| A materiovigilance study: The use of face masks in Romania considering the COVID-19 pandemic A Arseniu, AA Chis, A Frum, CM Dobrea, AM Juncan, LL Rus, G Cormos, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 394 (SUPPL 1), S56-S56, 2021 | | 2021 |
